Exenatide (shown on the right, PDB 7LLL), which was the first GLP-1 receptor agonist approved by the FDA, shares just over 50% sequence identity with GLP-1, but has a similar structure and is able to activate the GLP-1 receptor, while avoiding rapid proteolytic degradation
That said, weight loss in people with diabetes is still clinically meaningful and often leads to: Improved glucose control Reduced medication requirements Lower cardiovascular risk Better energy levels and mobility Important considerations GLP-1 medications are not cosmetic weight-loss drugs
All measurements were performed in 5-replicates
Wegovy is injected, so this particular interaction doesnt apply in the same way
Whole grains, such as quinoa and brown rice, along with natural sweeteners like honey or maple syrup in moderation, can satisfy your cravings without the detrimental effects of refined sugars